MCViewPoint

Opinion from a Libertarian ViewPoint

New York is Using Race to Determine Access to a Limited Supply of Life-Saving COVID Treatments

Posted by M. C. on January 2, 2022

https://greenwald.substack.com/p/new-york-is-using-race-to-determine

Glenn Greenwald

Monoclonal Antibody Treatments Save Lives,” announcedthe New York City Department of Health in an October 26 public notice. These treatments “are available and lifesaving,” the agency said, noting that they “have averted at least 1,100 hospitalizations and at least 500 deaths among people treated in New York City.” The agency urged the public to seek out these monoclonal antibody treatments as soon as possible: “When given early after symptom onset, mAb treatments can decrease the risk of hospitalization and death due to COVID-19, which is why it is crucial to get tested for COVID-19 as soon as symptoms begin – the sooner someone is tested, the sooner treatment can begin.”

The city’s health agency quoted its own Health Commissioner Dr. Dave A. Chokshi: “the science shows that monoclonal antibody treatments work and can make all the difference when it comes to the severity of COVID-19 illness.” It thus urged that “treatment should be given as soon as possible after someone tests positive for COVID-19.” Studies from Pfizer, cited by the agency, independently demonstrated just how effective the company’s antiviral treatment, called Paxlovid, can be: it “decreased Covid-19-linked hospitalisation or mortality risk from any cause by 88%.”

New York City Department of Health Press Release, Oct. 26, 2021

But with the Omicron variant now the dominant COVID strain in New York, both the city and state are facing severe shortages in the availability of effective antiviral monoclonal treatments. While Pfizer claimed its antiviral treatment would work against Omicron, the New York State Department of Health issued a memo to all health care providers this week warning that “Sotrovimab (Xevudy) is the only authorized monoclonal antibody product expected to be effective against the omicron variant.” Yet due to “a significant surge in cases and reduced effectiveness of existing therapeutics due to the omicron variant,” the agency warned that “supplies of oral antivirals will be extremely limited initially.” As of this week, the agency also said the same of its monoclonal antibody treatment: “supplies of Sotrovimab are extremely limited.”

See the rest here

Be seeing you

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

 
%d bloggers like this: